Molecular Partners AG (MOLN): a biotech net-net with institutional buying
turningroughstones.substack.com
Molecular Partners AG mainly develops drugs against cancer. To get the information for this post I had a look into the business update for the first half of 2024, the financial statements for the third quarter of 2023 (30 September 2023) and the annual report over 2022.
Molecular Partners AG (MOLN): a biotech net-net with institutional buying
Molecular Partners AG (MOLN): a biotech…
Molecular Partners AG (MOLN): a biotech net-net with institutional buying
Molecular Partners AG mainly develops drugs against cancer. To get the information for this post I had a look into the business update for the first half of 2024, the financial statements for the third quarter of 2023 (30 September 2023) and the annual report over 2022.